PharmaNutra SpA PHN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €48.15
- Day Range
- €48.00–49.10
- 52-Week Range
- €43.55–63.50
- Bid/Ask
- €47.55 / €49.10
- Market Cap
- €471.13 Mil
- Volume/Avg
- 3,656 / 7,455
Key Statistics
- Price/Earnings (Normalized)
- 30.60
- Price/Sales
- 4.68
- Dividend Yield (Trailing)
- 1.73%
- Dividend Yield (Forward)
- 1.73%
- Total Yield
- 1.75%
Company Profile
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, Asia, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 111
- Website
- https://www.pharmanutra.it
Comparables
Valuation
|
Metric
|
PHN
|
ISP
|
AMP
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.60 | 7.95 | 43.36 |
Price/Book Value | 8.26 | 1.12 | 6.19 |
Price/Sales | 4.68 | 2.39 | 3.06 |
Price/Cash Flow | 32.72 | 6.07 | 16.13 |
Price/Earnings
PHN
ISP
AMP
Financial Strength
|
Metric
|
PHN
|
ISP
|
AMP
|
|---|---|---|---|
Quick Ratio | 1.66 | — | 0.46 |
Current Ratio | 2.15 | — | 0.54 |
Interest Coverage | 21.57 | — | 5.31 |
Quick Ratio
PHN
ISP
AMP
Profitability
|
Metric
|
PHN
|
ISP
|
AMP
|
|---|---|---|---|
Return on Assets (Normalized) | −1.82% | 0.86% | 4.47% |
Return on Equity (Normalized) | −3.73% | 14.67% | 15.24% |
Return on Invested Capital (Normalized) | −1.86% | — | 7.64% |
Return on Assets
PHN
ISP
AMP
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Cntgchnms | Mpsdp | $79.8 Bil | |||
| Merck KGaA ADR
MKKGY
| Gckhtlwq | Jxzfts | $71.7 Bil | |||
| Haleon PLC ADR
HLN
| Bhbfhfpw | Vqbt | $37.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Hhqrlspnh | Fkr | $13.0 Bil | |||
| Viatris Inc
VTRS
| Mdhwlvd | Jxcy | $12.3 Bil | |||
| Catalent Inc
CTLT
| Xwgcgzvh | Lmqph | $10.3 Bil | |||
| Perrigo Co PLC
PRGO
| Zgvdhrvs | Dtcq | $3.5 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Kzygzmvtn | Grsgvs | $3.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Nmzkhsv | Xmtm | $2.8 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Rngwgknq | Qpjd | $2.7 Bil |